Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HP1BP3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
mRNA | SHANK3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | TUBB2A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | CTH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | TRAP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | HOXD3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | DNAJA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | PLOD3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
mRNA | FAM193B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | EMX1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |